Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 318,296 | 288,983 | 244,750 | 183,615 | 152,405 |
| Cost of Goods | 230,557 | 202,821 | 167,228 | 152,508 | 133,636 |
| Gross Profit | 87,739 | 86,162 | 77,522 | 31,107 | 18,769 |
| Operating Expenses | 132,817 | 67,939 | 46,370 | 47,108 | 41,078 |
| Operating Income | -44,521 | 19,044 | 31,380 | -15,493 | -21,673 |
| Interest Expense | 770 | 2,188 | 930 | 1,567 | 4,195 |
| Other Income | -2,790 | -678 | 39 | 243 | -554 |
| Pre-tax Income | -48,081 | 16,178 | 30,489 | -16,817 | -26,422 |
| Income Tax | -26,199 | -20,773 | 895 | N/A | N/A |
| Net Income Continuous | -21,882 | 36,951 | 29,594 | -16,817 | -26,422 |
| Net Income | $-21,882 | $36,951 | $29,594 | $-16,817 | $-26,422 |
| EPS Basic Total Ops | -0.67 | 1.16 | 1.01 | -0.60 | -1.31 |
| EPS Basic Continuous Ops | -0.67 | 1.16 | 1.01 | -0.60 | -1.31 |
| EPS Diluted Total Ops | -0.67 | 1.13 | 0.99 | -0.60 | -1.31 |
| EPS Diluted Continuous Ops | -0.67 | 1.13 | 0.99 | -0.60 | -1.31 |
| EBITDA(a) | $-30,840 | $28,568 | $38,454 | $-9,497 | $-18,049 |